,i  #aaf? ,,congress  #b;d ,session  ,h4
 ,r4 #hije  ,,9 ,,! ,,h\se ,,(          
,,repres5tatives  ,decemb] #h1 #bjbj,mr4
 ,van ,drew introduc$ ! foll[+ bill2 :i*
 0 ref]r$ to ! ,committee on ,en]gy &   
,comm]ce  ,a ,,bill  ,to am5d ! ,f$]al  
,food1 ,drug1 & ,cosmetic ,act to r$uce 
! ?reat ( c\nt]feit drugs to !          
ph>maceutical supply *a91 & to make !   
ph>maceutical supply *a9 m robu/1 :ile  
ensur+ ! au!nticity1 cont5t1 purity1 &  
manufactur+ location & bat* numb] (     
drugs 7includ+ ,,covid-#ai !rapeutics & 
vacc9es7 & all[+ pati5t v]ification (   
au!nticity1 & = o!r purposes4  #a4 ,%ort
 title ,?is ,act may be cit$ z ! ,supply
 ,*a9 ,security & ,ph>maceutical        
,au!ntication ,act ( #bjbj4  #b4        
,packages subject to ph>maceutical      
di/ribution supply *a9 requirem5ts      
,subp>agraph 7,b7 ( section #eha7aa7 ( !
 ,f$]al ,food1 ,drug1 & ,cosmetic ,act  
7#ba ,u4,s4,c4 #cfj;eee7#aa77 is am5d$  
to read z foll[s3  7,b7 ,individual     
saleable unit ,= purposes ( ?is         

p>agraph1 an individual saleable unit is
 ! smalle/ solid oral dosage =m (       
product1 or o!r individual solid oral   
dosage =m ( product1 introduc$ into     
comm]ce by ! manufactur] or repackag]4  
4